Minaris Advanced Therapies

Highly Engaged Employees

Minaris Advanced Therapies operates as a specialized contract development and manufacturing organization (CDMO) within the biotechnology and pharmaceutical sectors. The company focuses on the complex manufacturing of cell and gene therapies, providing comprehensive regulatory support and advanced testing services. Their technical capabilities encompass GMP manufacturing, process development, and biosafety testing for diverse therapeutic modalities, including CAR-T, viral vectors, and vaccines. By maintaining rigorous quality standards, the firm supports clients throughout the entire product lifecycle, from initial early-stage development to full-scale commercial launch.

The organization maintains a robust operational footprint with 500-1,000 employees dedicated to advancing therapeutic access. Minaris Advanced Therapies leverages over 25 years of industry experience to deliver high-quality manufacturing services. Their infrastructure is designed to handle the unique requirements of advanced therapies, ensuring compliance with global regulatory standards. The company operates from a primary facility in Philadelphia, Pennsylvania, which serves as a central hub for their technical operations and client-facing services. This strategic location allows for efficient coordination of complex manufacturing batches and clinical supply chain management.

Minaris Advanced Therapies continues to pioneer solutions in the cell and gene therapy space, aiming to accelerate the delivery of life-changing treatments to patients worldwide. Their commitment to technical excellence and regulatory compliance positions them as a key partner for biotech firms seeking reliable manufacturing and development support. Meet Minaris Advanced Therapies's team to learn more about the experts driving these innovations. The company’s focus on high-quality, scalable manufacturing processes remains a cornerstone of their market presence, ensuring that they meet the evolvingView more...